As on Wednesday, EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) started slowly as it slid -10.87% to $11.73, before settling in for the price of $13.16 at the close. Taking a more long-term approach, EYPT posted a 52-week range of $3.91-$14.91.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 15.65%. Meanwhile, its Annual Earning per share during the time was 15.65%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -29.54%. This publicly-traded company’s shares outstanding now amounts to $68.89 million, simultaneously with a float of $60.48 million. The organization now has a market capitalization sitting at $808.51 million.
EyePoint Pharmaceuticals Inc (EYPT) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. EyePoint Pharmaceuticals Inc’s current insider ownership accounts for 12.25%, in contrast to 89.93% institutional ownership. According to the most recent insider trade that took place on May 19 ’25, this organization’s Director bought 5,000 shares at the rate of 5.99, making the entire transaction reach 29,950 in total value, affecting insider ownership by 36,500. Preceding that transaction, on May 16 ’25, Company’s Director bought 5,000 for 5.81, making the whole transaction’s value amount to 29,050. This particular insider is now the holder of 31,500 in total.
EyePoint Pharmaceuticals Inc (EYPT) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.75 per share during the current fiscal year.
EyePoint Pharmaceuticals Inc’s EPS decrease for this current 12-month fiscal period is -29.54% and is forecasted to reach -3.02 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -3.62% through the next 5 years, which can be compared against the 15.65% growth it accomplished over the previous five years trading on the market.
EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) Trading Performance Indicators
Let’s observe the current performance indicators for EyePoint Pharmaceuticals Inc (EYPT). It’s Quick Ratio in the last reported quarter now stands at 7.91. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 15.58.
In the same vein, EYPT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.68, a figure that is expected to reach -0.77 in the next quarter, and analysts are predicting that it will be -3.02 at the market close of one year from today.
